Test identifies non-responders to first-line MS (multiple sclerosis) drug
This article was originally published in Clinica
Executive Summary
Testing for antibodies to interferon beta - the first-choice treatment for multiple sclerosis (MS) - could help identify patients who do not respond well to the drug.